Tyler Collins is a tax partner with over 12 years of experience in the profession. As the Market Leader of Withum’s R&D tax credit services, he helps clients maximize their tax savings by identifying and capturing eligible research and development expenses.
Driven by a passion for innovation and a commitment to excellence, Tyler provides expert guidance on navigating complex tax regulations, ensuring clients fully leverage available credits to fuel innovation and growth within their organizations. By optimizing R&D tax credits, businesses can invest more in research and development initiatives, driving technological advancement and competitive advantage in their industries.
Tyler is an integral member of Withum’s tax team. He assists in creating and executing the team’s strategic vision and short- and long-term plans.
Learn more about my professional experience and how I spend my time outside the firm.
Education:
Professional Affiliations:
As an industry expert, Tyler shares his knowledge through multiple avenues. He is a published author of several articles on the R&D tax credit and has been quoted by Thomson Reuters Tax and Accounting. Tyler has spoken at several CPE venues including the CPA Academy and AICPA ENGAGE.
Outside of the office, Tyler enjoys exploring new places and experiencing different cultures while traveling, particularly local cuisines, which he uses for inspiration in his own kitchen. When he is not jet-setting, he enjoys DIY house projects and transforming spaces with a touch of creativity.
For many startup companies, innovation comes long before profitability. While early-stage businesses often invest heavily in software development, product design, engineering or process improvement, they may have little or no federal income tax liability against which to utilize valuable tax credits. Recognizing this challenge, Congress created a special provision that allows startup companies to monetize…
For emerging life sciences companies, the Qualified Small Business (QSB) election under IRC §41(h) offers a critical opportunity to monetize research and development (R&D) tax credits by applying them against payroll tax liabilities. However, the strategic decision of when to first make the QSB election is often overlooked. Thoughtful timing, particularly in an industry characterized…
The life sciences industry, encompassing biotechnology, pharmaceuticals, medical devices and diagnostics, is uniquely positioned to benefit from the federal Research & Development (R&D) tax credit under IRC §41. This incentive rewards companies that invest in innovation, particularly where activities involve scientific uncertainty, experimentation and technological advancement. However, while many life sciences companies perform work that…